PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
12135555-6	2002	The purified CMP-Neu5Ac synthetase was used in the gram-scale synthesis of CMP-Neu5Ac.	cytidine-5'-monophosphosialic acid	13-23	cytidine monophosphate N-acetylneuraminic acid synthetase	Homo sapiens	24-34
23873973-3	2013	Functional studies included biochemical assays for N-glycosylation and mucin-type O-glycosylation and SLC35A1-encoded cytidine 5"-monophosphosialic acid (CMP-sialic acid) transport after heterologous expression in yeast.	cytidine-5'-monophosphosialic acid	118-152	solute carrier family 35 member A1	Homo sapiens	102-109
26669681-3	2016	A wide range of sialyltransferase (ST) inhibitors have been developed based on the natural donor, cytidine 5"-monophosphate N-acetylneuraminic acid (CMP-Neu5Ac).	cytidine-5'-monophosphosialic acid	149-159	ST6 beta-galactoside alpha-2,6-sialyltransferase 2	Homo sapiens	16-33
26397189-0	2015	Synthesis and biological evaluation of several dephosphonated analogues of CMP-Neu5Ac as inhibitors of GM3-synthase.	cytidine-5'-monophosphosialic acid	75-85	ST3 beta-galactoside alpha-2,3-sialyltransferase 5	Homo sapiens	103-115
32663509-7	2020	Furthermore, B3GNT2 overexpression enhanced intracellular UDP-GlcNAc and CMP-Neu5Ac content while slightly lowering UDP-Gal content.	cytidine-5'-monophosphosialic acid	73-83	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2	Cricetulus griseus	13-19
10356312-3	1999	The patient"s fibroblasts stored excess free NeuAc in the cytosolic fraction, and fibroblast UDP-GlcNAc 2-epimerase activity was only 26% inhibited by 100 microM CMP-Neu5Ac (normal, 79%).	cytidine-5'-monophosphosialic acid	162-172	renin binding protein	Homo sapiens	97-115
8314763-1	1993	Apparent kinetic parameters have been measured for the transfer of N-acetyl-D-neuraminic acid (Neu5Ac) from CMP-Neu5Ac to analogues of the Gal(beta 1-4)GlcNAc (type II) and Gal(beta 1-3)GlcNAc (type I) substrates by the rat liver Gal(beta 1-4)GlcNAc alpha 2,6-sialyltransferase and the Gal(beta 1-3/4)GlcNAc alpha 2,3-sialyltransferase.	cytidine-5'-monophosphosialic acid	108-118	galanin and GMAP prepropeptide	Rattus norvegicus	230-277
8314763-1	1993	Apparent kinetic parameters have been measured for the transfer of N-acetyl-D-neuraminic acid (Neu5Ac) from CMP-Neu5Ac to analogues of the Gal(beta 1-4)GlcNAc (type II) and Gal(beta 1-3)GlcNAc (type I) substrates by the rat liver Gal(beta 1-4)GlcNAc alpha 2,6-sialyltransferase and the Gal(beta 1-3/4)GlcNAc alpha 2,3-sialyltransferase.	cytidine-5'-monophosphosialic acid	108-118	galanin and GMAP prepropeptide	Rattus norvegicus	286-335
32971290-5	2020	We present here two human ST6Gal I structures, which show for the first time the enzyme in the unliganded state and with the full donor substrate CMP-Neu5Ac bound.	cytidine-5'-monophosphosialic acid	146-156	ST6 beta-galactoside alpha-2,6-sialyltransferase 1	Homo sapiens	26-34
29740059-0	2018	Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells.	cytidine-5'-monophosphosialic acid	55-65	erythropoietin	Cricetulus griseus	127-130
29844237-3	2018	Ongoing work has shown that growth of 15253 in cytidine monophospho-N-acetylneuraminic acid (CMP-Neu5Ac)-containing medium enables binding to CD33/Siglec-3, a cell surface receptor that binds sialic acid, suggesting that lactose termini on LOSs of intact gonococci can be sialylated.	cytidine-5'-monophosphosialic acid	93-103	CD33 antigen	Mus musculus	142-146
29844237-3	2018	Ongoing work has shown that growth of 15253 in cytidine monophospho-N-acetylneuraminic acid (CMP-Neu5Ac)-containing medium enables binding to CD33/Siglec-3, a cell surface receptor that binds sialic acid, suggesting that lactose termini on LOSs of intact gonococci can be sialylated.	cytidine-5'-monophosphosialic acid	93-103	CD33 antigen	Mus musculus	147-155